BlackRock Fund Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.8M	Buy	1,714,727 +162,477	+10%	+$1.84M	﹤0.01%	2313
2016 Q3	$18.3M	Buy	1,552,250 +73,495	+5%	+$1.12M	﹤0.01%	2121
2016 Q2	$19.1M	Sell	1,478,755 -20,113	-1%	-$293K	﹤0.01%	2047
2016 Q1	$24M	Buy	1,498,868 +83,040	+6%	+$1.58M	0.01%	1880
2015 Q4	$40.5M	Sell	1,415,828 -169,482	-11%	-$4.7M	0.01%	1621
2015 Q3	$45.1M	Buy	1,585,310 +99,971	+7%	+$3.68M	0.01%	1486
2015 Q2	$53.4M	Buy	1,485,339 +50,949	+4%	+$1.59M	0.01%	1479
2015 Q1	$41.7M	Buy	1,434,390 +44,216	+3%	+$1.17M	0.01%	1628
2014 Q4	$29.3M	Buy	1,390,174 +69,854	+5%	+$1.38M	0.01%	1834
2014 Q3	$25.6M	Buy	1,320,320 +19,668	+2%	+$309K	0.01%	1796
2014 Q2	$20.3M	Buy	1,300,652 +91,572	+8%	+$1.48M	0.01%	2013
2014 Q1	$25M	Buy	1,209,080 +52,532	+5%	+$1.04M	0.01%	1872
2013 Q4	$14.9M	Buy	1,156,548 +721,722	+166%	+$10M	﹤0.01%	2146
2013 Q3	$5.07M	Buy	434,826 +56,241	+15%	+$462K	﹤0.01%	2805
2013 Q2	$1.75M	Buy	+378,585	New	+$1.39M	﹤0.01%	3118